Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs7340831 | chr4:78961416 | A/T | 0 | 178 | 2.93 | 25.87 | 25.28 | KM Plot |
PCPG | rs7341735 | chr9:36126771 | T/C | 0 | 177 | 25.47 | 26.05 | 2.93 | KM Plot |
PCPG | rs73420376 | chr15:56283648 | T/C | 0.000465 | 174 | 25.2 | 26.53 | 21.55 | KM Plot |
PCPG | rs73441745 | chr22:50237606 | G/A | 0.000161 | 176 | 25.6 | 20.17 | 15.18 | KM Plot |
PCPG | rs73441772 | chr22:50258709 | C/T | 0.000172 | 177 | 25.28 | 20.2 | 15.18 | KM Plot |
PCPG | rs734488 | chr22:49578285 | G/A | 0.000167 | 174 | 28.3 | 23.37 | 25.17 | KM Plot |
PCPG | rs73454228 | chr7:134567584 | A/G | 6.94E-6 | 176 | 25.87 | 24.75 | 6.1 | KM Plot |
PCPG | rs734559 | chr18:72179579 | G/A | 3.59E-6 | 176 | 24.7 | 28.83 | 10.3 | KM Plot |
PCPG | rs73504192 | chr19:14727017 | C/T | 6.41E-6 | 173 | 25.6 | 24.32 | 25.17 | KM Plot |
PCPG | rs7355711 | chr2:176198458 | A/T | 0.000115 | 178 | 25.28 | 28.95 | 6.62 | KM Plot |
PCPG | rs73568761 | chr11:112970636 | C/T | 8.39E-5 | 174 | 25.87 | 18.88 | 36.73 | KM Plot |
PCPG | rs73573720 | chr13:114155345 | G/A | 4.65E-12 | 177 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs7359455 | chr16:71827799 | T/C | 0.000155 | 174 | 25.17 | 26.57 | 6.58 | KM Plot |
PCPG | rs73603034 | chr20:5993194 | T/C | 0 | 178 | 25.67 | 23.08 | 2.93 | KM Plot |
PCPG | rs73603051 | chr20:6008509 | G/A | 0 | 177 | 25.67 | 22.63 | 2.93 | KM Plot |